Cell therapies offer the potential to transform treatment for serious medical conditions. 📩Download our infographic for a side-by-side comparison of two types of cell therapies in development > https://hubs.li/Q02J-8JL0 #cellandgene #biotech #celltherapies
關於我們
Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies. At Veristat, we collaborate with clients to support the rapid delivery of life-changing therapies, helping them make sound decisions amidst uncertainties. Our scientific experts design and conduct the global activities required for any clinical, regulatory, or commercialization program comprehensively and efficiently. With our focus on novel drug development and nearly 30 years of experience, our versatile approach and bold scientific thinking make the impossible possible. Depend on our game-changing expertise and reliable execution for fast results and positive impact to support your biologics and drugs to treat rare cancers, CNS/Neurological disorders, Endocrine/metabolic disorders, and infectious diseases. We are…Bold. Scientific. Versatile. Veristat. - Veristat has recently been made aware that unknown third parties that have no connection to Veristat are generating fake Veristat job postings, interviews, and even fake employment offers via emails, websites, and various social media platforms, seemingly for the purpose of fraudulently obtaining personal information from legitimate job candidates. All legitimate correspondence from Veristat will originate from our applicant tracking system (Jobvite) or an @veristat.com email address. If you have received outreach from someone claiming to be a member of our team please search our official LinkedIn company page (https://www.linkedin.com/company/veristat-llc), where all members of our authorized recruiting team can be identified, or contact us directly at talentacquisition@veristat.com. Be vigilant.
- 網站
-
http://www.veristat.com
外部Veristat連結
- 產業
- 研究服務
- 公司規模
- 501-1,000 名員工
- 總部
- SouthboroughMassachusetts
- 類型
- 私人所有
- 專長
- Strategic Consulting、Safety Management、Data Management、Biostatistics、Statistical Programming、Project Management、Medical Writing、Regulatory Submissions、Adaptive Clinical Trial Design、Site Monitoring、Regulatory Consulting、Clinical Trial Patient Recruitment、Clinical Trial Data Standardization、Clinicl Trial Design、Clinical Trial Management、US Regulatory Agent、Pharmacovigilance、Marketing Applications Support、IND Support、Regulatory Publishing、Biologic、Gene Therapy、Full-service CRO和Oncology Clinical Trials
地點
Veristat員工
動態消息
-
Each August, Happiness Happens Day/Month celebrates moments and things that make us happy 🙂. It reminds us that spreading joy can help make the world a better place. Veristat’s Cares Committee was established to support our co-workers’ happiness and well-being. This summer, we set a ‘growing challenge’— from seed to bloom 🌱 — encouraging co-workers to share their successes and happiness when seeing the results of their nurturing come to life. Enjoy! #happinesshappensday
-
-
The European Commission announced a new association agreement between Bosnia and Herzegovina and the EU4Health program. The program and funding scheme will: 👉 Start retroactively from 1 January 2024 👉 Be accessible to both public and private entities 👉 Focus on improving specific areas such as: ✔ Cancer diagnosis ✔ Medicine stockpiling ✔ Healthcare digitalization ✔ Cross-border health threats Learn more > https://hubs.li/Q02J-f5g0 #Innovation #digitaltransformation #EU4Health
-
Tight timelines and staffing issues to meet your clinical trial milestones? Our FSP resourcing solutions can help eliminate your resourcing challenges. Find out more > https://hubs.li/Q02J-fkp0 #biopharma #biotech #clinicaltrials
FSP/Resourcing: Meeting the Moment with Expert Resources
veristat.com
-
The European Medicines Agency announced the allocation of a grant to support joint continual evaluation procedures in Africa. The pilot aims to: 📌 Lead to the establishment of the African Medicines Agency 📌 Evaluate the quality, safety and efficacy of priority medicines 📌 Build on the expertise of the African Union Development Agency’s Evaluation of Medicinal Products Technical Committee (EMP-TC) 📌 Rely on the support of the Good Manufacturing Practices Technical Committee (GMP-TC) Learn more > https://hubs.li/Q02J-f1z0 #RegulatoryFramework #pharmaceutical #healthcare
Milestone towards establishing the African Medicines Agency
ema.europa.eu
-
Tailored to your trial's needs! Unlike one-size-fits-all approaches, our DMC Services are customized to offer the personalized, client-centric support large pharma requires. Learn more today > https://hubs.li/Q02J-bKV0 #CustomizedSolutions #DataMonitoring #ClinicalTrials
Data Monitoring Committees in Clinical Trials - DMC, CEC, DSMB | Veristat
veristat.com
-
The FDA published the 2023 report of the Office of Surveillance and Epidemiology (OSE) detailing its achievements and future activities such as: ➡ Preparing the Sentinel System award contract ➡ Exploring new methods (e.g. AI to increase the efficiency of the Adverse Event Reporting System FAERS) ➡ Seeking science-driven approaches to risk evaluation and mitigation strategies REMS assessments ➡ Strengthening OSE information-sharing with international partners and supporting global harmonization Learn more > https://hubs.li/Q02J-fD20 #DataGovernance #pharmacovigilance
Office of Surveillance and Epidemiology 2023 Annual Report
fda.gov
-
✨Big news in cancer clinical trials - The FDA released three draft guidance documents in April 2024, broadening trial eligibility while aiming to enhance patient diversity and participation by recommending more flexible criteria for: 👉 Laboratory values 👉 Washout periods 👉 Concomitant medications Find out more > https://hubs.li/Q02J-cnV0 #FDA #CancerResearch #ClinicalTrials
FDA guidance on cancer clinical trial eligibility
veristat.com
-
The EU Parliament’s subcommittee on Public Health SANT published a report on mitigating disinformation in the area of public health. The report: 👉 Depicts the causes and channels of disinformation 👉 Investigates their impact on EU initiatives 👉 Maps out new emerging challenges 👉 Proposes various recommendations to mitigate disinformation Learn more > https://hubs.li/Q02J-6bQ0 #EU #healthcare #patientcare
EU Parliament publishes report on how to counter health disinformation
europarl.europa.eu
-
Market your therapeutic product in Europe and Switzerland with confidence. To ensure quality oversight, our QA and GxP compliance experts provide strategic and hands-on operational support, including acting as an EU qualified person (QP) or local Swiss responsible person (RP). Learn more > https://hubs.li/Q02J9rRW0 #biotech #biopharma
Commericalization - Quality Assurance | Veristat
veristat.com